University of Manchester researchers funded by Breast Cancer Now have discovered a new explanation as to why women with oestrogen receptor positive (ER+) breast cancer develop resistance to hormone treatment, and a potential new approach to overcome the problem.

Read this article:
Manchester researchers reveal why ER+ breast cancer women develop resistance to hormone therapy

Scroll to Top